Aston Health to Launch the Project "Routing of Patients for Purposes of Cancer Testing under OMS "

Publication date: 24 march 2020

The project is aimed at providing information and logistics support in routing of patient biomaterials for molecular genetic and immunohistochemical testing in the diagnostic centers across Russia. The testing is for NCLC, squamous cell carcinoma of the head and neck, urothelial cancer, stomach cancer, cervical cancer and colorectal cancer.

We invite pharmaceutical companies, testing labs and clinicians to take part in this project.

For more detailed information, please contact the head of the department of laboratory diagnostics development programs Natalia Mueva, Head of Laboratory Diagnostics, Aston Health at n.mueva@aston-health.com  or by phone +7 (495) 620-0914, (ext. 168).

Information about Aston Health

Since 1998, Aston Health provides valuable technology solutionsб as well as RWD/RWE to the players of the Russian pharmaceutical and healthcare market, including pharmaceutical manufacturers, distributors, pharmacy chains, medical and patient communities, government agencies and professional associations.

The key areas of focus are:

Clinical Patient Registries and Observational Programs Diagnostic Programs and patient targeting Marketing, GR and Market Access Patient Support Programs Training Programs for HCPs and patients Pharmaceutical market intelligence Website: https://aston-health.com/
Phone: +7 (495) 620-0914/15
E-mail: info@aston-health.com